Nvidia Backs Recursion with $50M for AI-Power...

In this episode, we examine the S&P 500's refusal to allow SpaceX's fast-track entry, which also impacts OpenAI and Anthropic’s IPO prospects. We also discuss Google's $920 million monthly deal with SpaceX for AI compute power and escalating enterprise spending on AI token budget ...  Show more

In this episode, we explore Alphabet's ambitious plan to raise $80 billion for AI development, including a major investment from Berkshire Hathaway. We also discuss Trump's recent executive order on AI regulation, GitHub's controversial pricing changes, and the shifting landscape ...  Show more

Dive into the future of pharmaceutical innovation as Nvidia commits a significant $50 million investment into Recursion, a pioneering AI drug discovery firm. Explore the potential breakthroughs and advancements at the intersection of artificial intelligence and life-saving med ...

In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its ...  Show more

In this episode, we delve into the transformative potential of generative AI and the new security challenges it presents, exploring how confidential computing provides a novel solution to these concerns. Discover how this innovative technology is revolutionizing data security, fo ...  Show more

In this episode, we delve into Qualtrics' recent announcement of their new, cutting-edge AI tool, exploring its functionalities and potential impact on businesses. We also discuss their monumental $500 million investment into AI, uncovering the company's strategic vision and what ...  Show more